The Assistance Publique Hopitaux de Paris (APHP) has selected Bruker´s IVD MALDI Biotyper as its exclusive MALDI-TOF mass spectrometry-based microbial identification tool.

Bruker’s proprietary MALDI Biotyper solution enables molecular identification, taxonomical classification or dereplication of microorganisms like bacteria, yeasts and fungi.

As an immediate result of the selection, the three Hospitals Bichat, Cochin and Lariboisiere have each ordered an IVD MALDI Biotyper system.

Additionally, the Hospitals Necker and Pitié-Salpétrière had previously selected and have already been working with Bruker´s MALDI-TOF mass spectrometers for several years.

The APHP hospitals will use the IVD MALDI Biotyper for mass spectrometry-based identification of microorganisms, such as gram-negative bacteria, gram-positive bacteria and yeasts.

MALDI Biotyper-based microbial identification is currently more and more replacing classical biochemical identification approaches, due to typically much faster time-to-result (TTR) and lower consumables cost.

The setup of the ISMABIOs regional network for the surveillance and treatment of bone and joint infection, jointly funded by the Region Ile de France through the DIM Malinf program and AP-HP, the hospital of Versailles and the hospital Croix Saint Simon will use MALDI-TOF based bacterial identification to achieve rapid and exact microbial identification in this demanding task.

APHP, an association of all 44 public hospitals in Paris, is a public health network in France. It is providing medical service for the complete metropolitan area of Paris with more than 10 million inhabitants.